Canopy Growth Corporation (CGC) concluded trading on Thursday at a closing price of $1.34, with 4.8 million shares of worth about $6.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -66.83% during that period and on May 15, 2025 the price saw a loss of about -4.96%. Currently the company’s common shares owned by public are about 180.08M shares, out of which, 179.16M shares are available for trading.
Stock saw a price change of 0.00% in past 5 days and over the past one month there was a price change of 32.67%. Year-to-date (YTD), CGC shares are showing a performance of -51.09% which decreased to -85.71% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.77 but also hit the highest price of $11.95 during that period. The average intraday trading volume for Canopy Growth Corporation shares is 7.12 million. The stock is currently trading 0.79% above its 20-day simple moving average (SMA20), while that difference is up 15.52% for SMA50 and it goes to -58.51% lower than SMA200.
Canopy Growth Corporation (NASDAQ: CGC) currently have 180.08M outstanding shares and institutions hold larger chunk of about 7.99% of that.
The stock has a current market capitalization of $241.31M and its 3Y-monthly beta is at 0.78. It has posted earnings per share of -$3.81 in the same period. It has Quick Ratio of 2.58 while making debt-to-equity ratio of 0.83. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CGC, volatility over the week remained 6.90% while standing at 11.74% over the month.
Stock’s fiscal year EPS is expected to rise by 47.93% while it is estimated to increase by 76.65% in next year. EPS is likely to grow at an annualized rate of 60.04% for next 5-years, compared to annual growth of 20.88% made by the stock over the past 5-years.
Coverage by Bernstein stated Canopy Growth Corporation (CGC) stock as an Underperform in their note to investors on November 02, 2022, suggesting a price target of $1.50 for the stock. Stock get an Underweight rating from Barclays on March 22, 2022.
